Patent details

Basic Information

Publication number:

EP2861216

PCT Application Number:

EP2013062398

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137290292

PCT Publication Number:

WO2013186370

First applicant's nationality:

Translation Language:

EPO Publication Language:

French

English Title of Invention:

ORAL PHARMACEUTICAL FORMULATION OF BCS CLASS III MOLECULES

French Title of Invention:

FORMULATION PHARMACEUTIQUE ORALE DE MOLECULES BCS DE CLASSE III

German Title of Invention:

ORALE PHARMAZEUTISCHE FORMULIERUNG MIT BCS-KLASSE III-MOLEKÜLEN

SPC Number:

Dates

Filing date:

14/06/2013

Grant date:

17/04/2019

EP Publication Date:

22/04/2015

PCT Publication Date:

19/12/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/04/2019

EP B1 Publication Date:

17/04/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/06/2019

Expiration date:

14/06/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/04/2019

 

 

Name:

Ethypharm

Address:

194 Bureaux de la Colline Bâtiment D, 92210 Saint-Cloud, France (FR)

Inventor

1

Name:

AILHAS, Caroline

Address:

France (FR)

2

Name:

HERRY, Catherine

Address:

France (FR)

Priority

Priority Number:

1255593

Priority Date:

14/06/2012

Priority Country:

France (FR)

Classification

IPC classification:

A61K 9/00; A61K 9/107; A61K 9/16; A61K 9/20; A61K 9/48; A61K 9/50; A61K 31/197; A61K 47/12; A61K 47/10; A61K 47/14;

Publication

European Patent Bulletin

Issue number:

201916

Publication date:

17/04/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages